SRI 37892
Product Specifications
UNSPSC Description
SRI 37892 is a small molecule compound inhibitor of Frizzled protein 7 (Fzd7) with inhibitory activity against cancer cell proliferation (IC502μM). SRI 37892 significantly blocks Wnt/Fzd7 signaling. SRI 3789 can be used in the research of developing cancer therapeutic agents [1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sri-37892.html
Purity
98.92
Solubility
10 mM in DMSO
Smiles
O=C(NC1=NC(C2=CC3=C(NC(CC3)=O)C=C2)=CS1)C4=CC=C(N5C6=CC=CC=C6N=C5)C=C4
Molecular Weight
465.53
References & Citations
[1]Zhang W, et al. Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain. Oncotarget. 2017 Sep 6;8(53):91459-91470.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-117002/SRI-37892-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-117002/SRI-37892-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1030769-75-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6177495-01 0.1 mL
FAAH (Fatty Acid Amide Hydrolase, FAAH-1, MGC102823, MGC138146) (FITC)
Ask
View Details 
MBS6177495-02 5x 0.1 mL
FAAH (Fatty Acid Amide Hydrolase, FAAH-1, MGC102823, MGC138146) (FITC)
Ask
View Details 
MBS7066124 Inquire
Recombinant Clostridium phytofermentans UPF0059 membrane protein Cphy_1637 (Cphy_1637), partial
Ask
View Details